Hemostemix Inc. (TSXV:HEM)
Canada · Delayed Price · Currency is CAD 0.0600
0.00 (0.00%)
Oct 29, 2026, 3:56 PM EDT
Hemostemix Market Cap
Hemostemix has a market cap or net worth of CAD 12.69 million as of October 30, 2026. It is the 41,926th most valuable company in the world and the 1,470th biggest in Canada. Its market cap has decreased by 23.27% in one year.
Market Cap
12.69M
Enterprise Value
16.05M
Revenue
n/a
Global Rank
Country Rank
#1,470 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since November 28, 2014, Hemostemix's market cap has decreased from 48.88M to 12.69M, a decrease of -74.05%. That is a compound annual growth rate of -10.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 12.69M | -27.81% |
| Dec 31, 2025 | 17.57M | 3.39% |
| Dec 31, 2024 | 17.00M | 178.71% |
| Dec 29, 2023 | 6.10M | -55.27% |
| Dec 30, 2022 | 13.63M | 44.06% |
| Dec 31, 2021 | 9.46M | -70.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Devonian Health Group | 20.86M |
| Onco-Innovations | 18.69M |
| Pharmala Biotech Holdings | 17.55M |
| Rapid Dose Therapeutics | 15.16M |
| Lobe Sciences | 13.58M |
| Alzai Health | 12.96M |
| PreveCeutical Medical | 12.76M |
| Britannia Life Sciences | 11.52M |